148 related articles for article (PubMed ID: 21295407)
21. miR-183 cluster scales mechanical pain sensitivity by regulating basal and neuropathic pain genes.
Peng C; Li L; Zhang MD; Bengtsson Gonzales C; Parisien M; Belfer I; Usoskin D; Abdo H; Furlan A; Häring M; Lallemend F; Harkany T; Diatchenko L; Hökfelt T; Hjerling-Leffler J; Ernfors P
Science; 2017 Jun; 356(6343):1168-1171. PubMed ID: 28572455
[TBL] [Abstract][Full Text] [Related]
22. Targeting TRPV1 as an alternative approach to narcotic analgesics to treat chronic pain conditions.
Premkumar LS
AAPS J; 2010 Sep; 12(3):361-70. PubMed ID: 20440589
[TBL] [Abstract][Full Text] [Related]
23. Intravenous recombinant cerebellin 1 treatment restores signalling by spinal glutamate delta 1 receptors and mitigates chronic pain.
Sabnis SS; S Narasimhan KK; Chettiar PB; Gakare SG; Shelkar GP; Asati DG; Thakur SS; Dravid SM
Br J Pharmacol; 2024 May; 181(9):1421-1437. PubMed ID: 38044332
[TBL] [Abstract][Full Text] [Related]
24. The genetic mediation of individual differences in sensitivity to pain and its inhibition.
Mogil JS
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7744-51. PubMed ID: 10393892
[TBL] [Abstract][Full Text] [Related]
25. Regulatory T cell-derived enkephalin imparts pregnancy-induced analgesia.
Midavaine É; Moraes BC; Benitez J; Rodriguez SR; Braz JM; Kochhar NP; Eckalbar WL; Domingos AI; Pintar JE; Basbaum AI; Kashem SW
bioRxiv; 2024 May; ():. PubMed ID: 38798460
[TBL] [Abstract][Full Text] [Related]
26. Defining and Managing Pain in Stroke and Traumatic Brain Injury Research.
Larson CM; Wilcox GL; Fairbanks CA
Comp Med; 2019 Dec; 69(6):510-519. PubMed ID: 31896392
[TBL] [Abstract][Full Text] [Related]
27. Pain persists in mice lacking both Substance P and CGRPα signaling.
MacDonald DI; Jayabalan M; Seaman J; Nickolls A; Chesler A
bioRxiv; 2023 Nov; ():. PubMed ID: 38076807
[TBL] [Abstract][Full Text] [Related]
28. A machine-vision approach for automated pain measurement at millisecond timescales.
Jones JM; Foster W; Twomey CR; Burdge J; Ahmed OM; Pereira TD; Wojick JA; Corder G; Plotkin JB; Abdus-Saboor I
Elife; 2020 Aug; 9():. PubMed ID: 32758355
[TBL] [Abstract][Full Text] [Related]
29. Human birth tissue products as a regenerative medicine to inhibit post-surgical pain through multi-modal action.
Zhang C; Huang Q; Ford NC; Limjunyawong N; Lin Q; Yang F; Cui X; Uniyal A; Liu J; Mahabole M; He H; Wang XW; Duff I; Wang Y; Wan J; Zhu G; Raja SN; Jia H; Yang D; Dong X; Tseng SC; He SQ; Guan Y
bioRxiv; 2024 May; ():. PubMed ID: 38826432
[TBL] [Abstract][Full Text] [Related]
30. Massage-like stroking produces analgesia in mice.
Waarala ZMS; Comins L; Laumet S; Folger JK; Laumet G
Neurobiol Pain; 2024; 15():100149. PubMed ID: 38226332
[TBL] [Abstract][Full Text] [Related]
31. The Study of Pain in Rats and Mice.
Larson CM; Wilcox GL; Fairbanks CA
Comp Med; 2019 Dec; 69(6):555-570. PubMed ID: 31822322
[TBL] [Abstract][Full Text] [Related]
32. Venom-inspired somatostatin receptor 4 (SSTR4) agonists as new drug leads for peripheral pain conditions.
Bjørn-Yoshimoto WE; Ramiro IBL; Koch TL; Engholm E; Yeung HY; Sørensen KK; Goddard CM; Jensen KL; Smith NA; Martin LF; Smith BJ; Madsen KL; Jensen KJ; Patwardhan A; Safavi-Hemami H
bioRxiv; 2024 Apr; ():. PubMed ID: 38746149
[TBL] [Abstract][Full Text] [Related]
33. WITHDRAWN: Sodium channel development and modulation of hypoxia and delta-opioid receptor on sodium channel expression in developing cortical neurons of rat brain.
Cao H; Ding Z; Zhong H; Gong S; Chen L; Li M
Mol Cell Biochem; 2008 Feb; ():. PubMed ID: 18239860
[No Abstract] [Full Text] [Related]
34. Mu opioid receptors on primary afferent nav1.8 neurons contribute to opiate-induced analgesia: insight from conditional knockout mice.
Weibel R; Reiss D; Karchewski L; Gardon O; Matifas A; Filliol D; Becker JA; Wood JN; Kieffer BL; Gaveriaux-Ruff C
PLoS One; 2013; 8(9):e74706. PubMed ID: 24069332
[TBL] [Abstract][Full Text] [Related]
35. A novel selective and orally bioavailable Nav 1.8 channel blocker, PF-01247324, attenuates nociception and sensory neuron excitability.
Payne CE; Brown AR; Theile JW; Loucif AJ; Alexandrou AJ; Fuller MD; Mahoney JH; Antonio BM; Gerlach AC; Printzenhoff DM; Prime RL; Stockbridge G; Kirkup AJ; Bannon AW; England S; Chapman ML; Bagal S; Roeloffs R; Anand U; Anand P; Bungay PJ; Kemp M; Butt RP; Stevens EB
Br J Pharmacol; 2015 May; 172(10):2654-70. PubMed ID: 25625641
[TBL] [Abstract][Full Text] [Related]
36. Mu and delta opioid receptors play opposite nociceptive and behavioural roles on nerve-injured mice.
Martínez-Navarro M; Cabañero D; Wawrzczak-Bargiela A; Robe A; Gavériaux-Ruff C; Kieffer BL; Przewlocki R; Baños JE; Maldonado R
Br J Pharmacol; 2020 Mar; 177(5):1187-1205. PubMed ID: 31655493
[TBL] [Abstract][Full Text] [Related]
37. The delta opioid receptor: an evolving target for the treatment of brain disorders.
Pradhan AA; Befort K; Nozaki C; Gavériaux-Ruff C; Kieffer BL
Trends Pharmacol Sci; 2011 Oct; 32(10):581-90. PubMed ID: 21925742
[TBL] [Abstract][Full Text] [Related]
38. TET1-Lipid Nanoparticle Encapsulating Morphine for Specific Targeting of Peripheral Nerve for Pain Alleviation.
Yang H; Liu Z; Liu F; Wu H; Huang X; Huang R; Saw PE; Cao M
Int J Nanomedicine; 2024; 19():4759-4777. PubMed ID: 38828199
[TBL] [Abstract][Full Text] [Related]
39. An Examination of the Complex Pharmacological Properties of the Non-Selective Opioid Modulator Buprenorphine.
Pande LJ; Arnet RE; Piper BJ
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895868
[TBL] [Abstract][Full Text] [Related]
40. Migraine Treatment: Towards New Pharmacological Targets.
Silvestro M; Iannone LF; Orologio I; Tessitore A; Tedeschi G; Geppetti P; Russo A
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
